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Adult neurogenesis research has made enormous strides in the last decade but has been compli-
cated by several failures to replicate promising findings. Prevalent use of highly sensitive methods
with inherent sources of error has led to extraordinary conclusions without adequate crossvalidation.
Perhaps the biggest culprit is the reliance on molecules involved in DNA synthesis and genetic
markers to indicate neuronal neogenesis. In this Protocol Review, we present an overview of com-
mon methodological issues in the field and suggest alternative approaches, including viral vectors,
siRNA, and inducible transgenic/knockout mice. A multipronged approach will enhance the overall
rigor of research on stem cell biology and related fields by allowing increased replication of findings
between groups and across systems.Stem cell biology is one of the fastest growing research
areas in biomedicine and attracts considerable attention
due to the potential for regenerative therapies of otherwise
irreplaceable tissues. Embryonic stem cells have been
isolated from many species, including humans. Also, res-
ident adult precursor/stem cells have been identified
in tissues such as the brain, bone marrow, intestine, and
skin, and there is increasing evidence of their presence
in other regions such as the muscle, kidney, and lung
(Nystul and Spradling, 2006).
Particular interest has been devoted to neural precur-
sor/stem cells and the regions displaying neurogenesis
in adult mammals (Gage, 2000; Sohur et al., 2006). This
is partially due to the often poor clinical prognosis of neu-
rodegenerative disease and neurotrauma as well as the
difficulty in deriving and transplanting neural tissue. Multi-
potent neural precursor cells (NPCs) have been derived
from many central nervous system (CNS) regions (Gage,
2000). Furthermore, these findings that the brain adds
new neurons to mature circuits in selected regions pro-
vides a model to assess how lost neurons might be re-
placed. As the identity of ‘‘true’’ CNS stem cells, defined
as being capable of giving rise to all types of CNS neurons,
oligodendroglia, and astroglia, is not yet established, we
use the term ‘‘precursor cell’’ to encompass the entire lin-
eage of neural stem and more restricted progenitor cells
(Sohur et al., 2006).612 Cell Stem Cell 1, December 2007 ª2007 Elsevier Inc.The recent explosion in the study of postnatal precursor
cells has developed in parallel with increasingly complex
techniques that allow for their precise labeling and manip-
ulation. However, some of these reports have not been ex-
empt from controversy, and the high scientific and social
expectations for this field may have led to the acceptance
of spectacular findings without sufficient supporting evi-
dence (Aldhous, 2006; Nowakowski and Hayes, 2000;
Rakic, 2002; Shaywitz, 2006). Indeed, some findings
have been difficult to reproduce—sometimes even by
the same lab (Aldhous, 2006)—and many claims of out-
standing basic and clinical achievements have been re-
futed due to methodological issues (see Vogel, 2003 and
references therein) or bias in the selection of patients
and experimental design (Aldhous, 2006). Furthermore,
data from the initial transplants of tumor-derived and
immortalized progenitors or partially differentiated neural
cells into clinical stroke patients do not show significant
functional improvements, in stark contrast with the results
from animal models on which they are based (see Bakay,
2005 for discussion and associated references; Kond-
ziolka et al., 2005).
The field of adult neurogenesis is particularly controver-
sial. There have been reports of constitutive neurogenesis
in the primate and rodent neocortex (Dayer et al., 2005;
Gould et al., 1999, 2001; Kaplan, 1981), the amygdala (Ber-
nier et al., 2002), areaCA1of the rodent (Rietze et al., 2000),
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2005), the spinal cord (Yamamoto et al., 2001), and the
substantia nigra (Zhao et al., 2003). To a large degree,
these reports remain unconfirmed or have been directly
challenged with negative findings, some identifying a pos-
sible cause of the original artifactual findings (Ackman
et al., 2006; Ekdahl et al., 2001; Frielingsdorf et al., 2004;
Hoglinger et al., 2007; Horner et al., 2000; Koketsu et al.,
2003; Kornack and Rakic, 2001; Lie et al., 2002; Magavi
et al., 2000). In some cases, even positive findings of neu-
rogenesis are notmutually crossvalidating, e.g., Gould and
colleagues reported the genesis of projection neurons in
the association neocortex, but not in the visual cortex
(Gould et al., 1999), whereas Kaplan reported neurogene-
sis in the rat neocortex only in the visual cortex (Kaplan,
1981). In addition, Gould and colleagues indicated that
new projection neurons could be generated in situ or po-
tentially from SVZ cells, whereas Cameron and colleagues
detected interneurons generated only in situ (Dayer et al.,
2005).With regard to human neurogenesis, a recent report
describing a rostral migratory stream in humans (Curtis
et al., 2007) is inconsistent with earlier studies by Al-
varez-Buylla and coworkers that did not detect migrating
neuron chains (Quinones-Hinojosa et al., 2006; Sanai
et al., 2004). The conclusions of this new report by Curtis
et al. have now been directly challenged (Sanai et al.,
2007). Lesion-induced neurogenesis is similarly confused
by unconfirmed or disputed findings (Frielingsdorf et al.,
2004; Hoglinger et al., 2007; Lie et al., 2002; Zhao et al.,
2003). Taken together, it appears that the individual tech-
niques currently employed to study neural precursor cells
have important caveats and limitations. Perhaps the most
significant constraint is the observer effect: namely, the
impact of the experimental manipulation itself on the pro-
cesses being studied. It is essential that these caveats
be adequately addressed by the experimental design
and considered during the interpretation of results.
A major contributor to the controversies noted above is
the lack of a reliable, definitive method to label new neu-
rons. In the present article, we will describe a range of
available methods for the labeling and modification of
neural precursor cells. Special emphasis is given to the
limitations and confounding factors that may lead to am-
biguous or inaccurate results and contribute to misinter-
pretation of the obtained data. It is hoped that the use of
a combination ofmethodswill circumvent theweaknesses
of single methods and allow for crossvalidation. As the
same techniques are used throughout related fields of
stem cell biology, we hope to give insight as to how these
methods might be applied rigorously to other systems.
Replication of data is one of the foundations of scientific
advancement, and we believe that by raising awareness
of several key issues, the rigor and reliability of this matur-
ing field can be optimized.
Thymidine Analog Methods for Neural
Precursor Identification
The first evidence of the existence of postnatal precursor
cells in the brain was obtained with tritiated thymidine(3H-dT). This nucleotide analog is incorporated during
DNA synthesis and therefore labels all cells that pass
through the S phase of the cell cycle during 3H-dT expo-
sure. The resulting signal can be detected by autoradiog-
raphy of tissue sections and is proportional to the amount
of DNA synthesized, permitting the observation of the
origin, migration, and fate of newly born cells. This method
allowed for the initial observation of precursor cells in the
subependymal zone of the lateral ventricles in the postna-
tal brain and in the dentate gyrus (DG) of the hippocampus
in rodents and primates (Rakic, 2002). However, the radio-
activity of this label, the time-consuming nature of autora-
diography, and the inability to sample beyond the upper
few microns of a tissue section were inherent limitations
to this technique (Table 1). In addition, 3H-dT is toxic under
certain circumstances, causing mutations, DNA strand
breaks, chromosomal abnormalities, and cell death (Eh-
mann et al., 1975). Of note, these authors warned of sev-
eral pitfalls in the use of thymidine analogs that often go
unheeded, even some 30 years later, as discussed below.
To counter the limitations specific to 3H-dT, the analog
bromodeoxyuridine (BrdU) was adapted for use in neural
tissues (Miller and Nowakowski, 1988). Detection of
BrdU via immunocytochemistry using a specific monoclo-
nal antibody yields an amplifiable signal and expands the
depth of tissue sections that can be imaged relative to
3H-dT autoradiography. Of course, amplification tech-
niques can exaggerate the magnitude of DNA synthesis
(Rakic, 2002) or lead to false-positive readings (Bak and
Panos, 1997), emphasizing the importance of appropriate
controls duringBrdUanalysis (McGinley et al., 2000) (Table
1). In addition to the improved sensitivity over 3H-dT, fluo-
rescently labeled secondary antibodies used in BrdU
detection can be combined with up to three additional
primary antibodies for simultaneous cell characterization
(Kornack and Rakic, 2001; Magavi et al., 2000). However,
precise colocalization remains challenging in regions with
a high density of cell bodies such as the granular layer of
the DG. This is particularly difficult if the cell marker is not
expressed in the nucleus, as is the case with the astrocytic
marker glial fibrillary acidic protein (Gfap). BrdU labeling of
DNAwaspivotal in the report of neurogenesis in the human
hippocampus and the lack of neurogenesis in the human
neocortex (Bhardwaj et al., 2006; Eriksson et al., 1998).
Despite its advantages, the use of BrdU to track dividing
cells can also introduce cellular changes due to the pres-
ence of the incorporated BrdU molecules. The molecular
structure of BrdU is significantly different from the natural
structure of thymidine (Stetson et al., 1988) (Figure 1) and
may cause steric hindrance when present in high quanti-
ties. The resulting impact of high doses of BrdU on the nat-
ural conformation of the DNA can alter transcription and
translation and may lead to mutation and cell toxicity
(Table 1), compromising the cellular function and even
the overall health of the subject. Indeed, BrdU is well
known for its ability to sensitize cancer cells to radiation
(Djordjevic and Szybalski, 1960). In vitro, BrdU can be se-
lectively toxic to neurons when used at currently recom-
mended concentrations (Caldwell et al., 2005) and canCell Stem Cell 1, December 2007 ª2007 Elsevier Inc. 613
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Method Means of Delivery Cell Types Targeted Advantages Caveats
Thymidine Analogs
Tritiated
thymidine
Peripheral or
local
injection
Cells
synthesizing
DNA
Widespread labeling
of proliferating cells
Taken up by cells undergoing
abortive mitosis and by cells
repairing DNA
Stoichiometric detection ratio Causes DNA strand breaks
Dilutes during every
replication cycle
BrdU, CldU,
IdU
Peripheral
or local
injection
Cells
synthesizing
DNA
Widespread labeling
of proliferating cells
Taken up by cells undergoing
abortive mitosis and by cells
repairing DNA
Detection methods amplify
signal
Causes DNA strand breaks, DNA
transcription errors, mutagenic
Allows for phenotyping of labeled
cells in thick tissue sections
Highly toxic
Dilutes during every replication
cycle
Amplification in detection method
obscures nature of DNA synthesis
Viral Vectors
Adenovirus Stereotaxic,
focal injection
Broad range Widespread injection
of most tissues
Transient transduction
Pantrophic Subcloning of transgenes typically
requires shuttle
8 kb insert (helper virus
permits larger inserts)
Not specific for newborn cells
Focal injection by its nature
causes lesion
Lentivirus Stereotaxic,
focal injection
Broad range Persistent genetic alteration
of most tissues
Genomic integration disrupts host
DNA at insertion site
Pantrophic Not specific for newborn cells
8 kb insert Focal injection by its nature
causes lesion
Retrovirus Stereotaxic,
focal injection
Dividing cells Persistent genetic alteration
of dividing transduced cells
Genomic integration disrupts
host DNA at insertion site
Pantrophic Induced fusion reported
7.5 kb insert Focal injection by its nature
causes lesionalso induce aberrant neuronal differentiation (Qu et al.,
2004). In vivo, high doses of BrdU can induce abnormal
proliferation (Goldsworthy et al., 1992) and act as a muta-
gen, teratogen, and carcinogen. The toxicity is expected
to correlate with the number of cells that incorporate
BrdU and with the percentage of thymidine nucleotides
that are replaced (Bannigan and Langman, 1979; Banni-
gan et al., 1990; Kolb et al., 1999; Kuwagata et al., 2004;
Nagao et al., 1998). Therefore, increasing dosages and
frequency of injection are thought to exacerbate the cellu-
lar toxicity and adverse side effects, likely causing toxicity
in the very population that is under examination (Gold-
sworthy et al., 1992; Goldsworthy et al., 1993).614 Cell Stem Cell 1, December 2007 ª2007 Elsevier Inc.Although it has been recommended that doses of up to
300 mg/kg should be employed (Cameron and McKay,
2001), lower 50–100 mg/kg doses may minimize toxicity
and are adequate to reach near-saturation labeling (Burns
and Kuan, 2005). It should also be noted that numerous,
small doses that in total exceed 100–150 mg/kg per day
can also lead to adverse effects. For example, in attempt-
ing to label cerebellar cell types, Mugnaini and colleagues
noted that BrdU produced striking defects on the prolifer-
ation, migration, and localization of Purkinje neurons,
along with defects in the patterning of foliation (Sekerkova
et al., 2004). The distinct structure of the cerebellum,
with a single layer of Purkinje cell bodies that exhibit
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(A) Structure of thymidine and the thymidine analogs bromodeoxyuridine, chlorodeoxyuridine, and iododeoxyuridine. Halogens are not drawn to scale
in comparison to the nucleotide chemical structure, but an attempt was made to portray the relative sizes of the halogens when compared the methyl
group they substitute for. Alteration of molecular size is proposed to cause steric hindrance, affecting the natural structure of DNA and subsequent
synthesis/repair or transcription and translation.a characteristic dendritic tree, made the defect evident.
Postnatal neurogenic regions of the forebrain do not ex-
hibit such precise cellular lamination and organization,
opening the possibility that similar effects could be
missed.
Recently, several groups have reported that chloro-
deoxyuridine and iododeoxyuridine (both thymidine ana-
logs with a similar structure to BrdU [Figure 1]) can be
detected individually by different monoclonal antibodies
(Burns and Kuan, 2005). Using two temporally segregated
injections of these two molecules, two cohorts of S phase
cells may be tracked over the course of time. The recom-
mended precautions for BrdU studies also apply to these
related compounds.
An underappreciated phenomenon is the abortive cell
cycle that some neurons enter after insult (Burns et al.,
2007), during disease processes (Hoglinger et al., 2007;
Yang et al., 2001), or prior to death (Kruman et al., 2004;
Kuan et al., 2004). In certain cases, cycling neurons ap-
pear not to die (Burns et al., 2007) but they persist for
months or even years (Hoglinger et al., 2007; Yang et al.,
2001). As this type of aberrant cell cycle includes a full S
phase, cycling neurons may incorporate BrdU or other
thymidine analogs when in this state (Burns et al., 2007;
Hoglinger et al., 2007; Kuan et al., 2004), appearing new-
born although they did not divide (see below). It is impor-
tant to note that this is a distinct process from the small-
scale repair of DNA that many have tried to label with
BrdU in the context of adult neurogenesis (Bauer and Pat-
terson, 2005). Notably, this type of labeling has been ob-
served with 3H-dT in vitro (Sanes and Okun, 1972). How-
ever, the abortive cell cycle has also been linked with DNA
repair (Kruman et al., 2004). In addition, neurons undergo-
ing an abortive cell cycle can expressmarkers of immature
neurons such as b-III-tubulin (Kuan et al., 2004). Also note-
worthy are reports of aberrant DNA synthesis in postmi-
totic neurons after activation (Stillwell et al., 1973).
A simple practice for excluding the possibility of non-
proliferative BrdU incorporation is to include an assay for
incorporation at short times after injection (Magavi et al.,
2000; Sohur et al., 2006). Short 2–24 hr pulse experiments
would only label immature precursor cells or migratingneurons during the normal process of neurogenesis, and
any significant labeling of mature neurons would be evi-
dence of nonproliferative DNA synthesis. Significant num-
bers of mature BrdU-labeled neurons should only be
observed after relatively long chase time points, such as
2–4 weeks after the pulse. The study of two time points
within a single animal can be easily achieved by combined
CldU/IdU labeling, as discussed above. For example, an
injection of CldU is given several weeks prior to an injec-
tion of IdU, after which the subject is euthanized. Mature
cells should contain only CldU, and any mature neuron
marked with IdU likely underwent nonproliferative DNA
synthesis. Nonproliferative BrdU incorporation might
also be excluded by immunostaining for endogenous
markers of proliferation in combination with mature neuro-
nal markers. (It is important to note that NeuN expression
can be lost briefly under some conditions but return later,
likely precluding its use as a definitive marker in such
cases [McPhail et al., 2004].) As discussed in detail above,
using such a combination of methods, we, along with
many other groups, have seen robust BrdU labeling of
neurons in the absence of neurogenesis (Burns et al.,
2007; Hoglinger et al., 2007; Klein et al., 2002; Kuan
et al., 2004) (Figure 4). Examination of mitotic figures can
also be performed to ensure that BrdU incorporation is
proliferative in nature. If the levels of BrdU incorporation
do not correlate with observed mitotic figures, DNA syn-
thesis is likely independent of mitosis. Additionally, pre-
existing neurons can be prelabeled by other methods
such as retrograde tracers or fluorescent nanospheres
to avoid the risk of misinterpreting older cells as newborn
(Chen et al., 2004; Hoglinger et al., 2007; Magavi et al.,
2000).
Confirmation of BrdU-detected neurogenesis can also
be achieved by combining immunodetection of markers
that represent the stereotypical progression of neuronal
differentiation from precursor cell to neuron with the use
of functional methods such as electrophysiology (van
Praag et al., 2002) or retrograde labeling (Chen et al.,
2004; Hoglinger et al., 2007; Magavi et al., 2000). In the
search for newborn cells, however, markers such as dou-
blecortin, b-III-tubulin, or PSA-NCAM should be used notCell Stem Cell 1, December 2007 ª2007 Elsevier Inc. 615
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methods to confirm their specificity (Chen et al., 2004;
Magavi et al., 2000; Nacher et al., 2001). Furthermore,
as these markers correspond to specific cell morphol-
ogies, a rigorous criterion should be used to identify the
cells as migratory and not dying (Kuan et al., 2004; Magavi
et al., 2000) or upregulating particular markers due to
some sort of plastic response (Nacher et al., 2001,
2002). Migratory cells should possess a small nucleus (rel-
ative to mature projection neurons) and a relatively long
leading process. In any case, expression of these markers
in newborn cells should not be accepted as necessary and
sufficient proof of neuronal replacement, as it is known
that in many cases new cells do not survive or mature
into functionally integrated neurons (Arvidsson et al.,
2002; Parent et al., 2002).
Recently, a C14-based method has been adapted to
examine neurogenesis in the human brain—as BrdU injec-
tions are typically not possible. In rare cases, such as mi-
totic index analysis in cases of select malignancies, BrdU
has been given to human subjects (Bhardwaj et al., 2006;
Eriksson et al., 1998). The C14 method has been useful in
crossvalidating the nonexistence of significant levels of
neocortical neurogenesis in the postnatal primate brain
(Rakic, 2006). However, this methodology is expensive,
difficult to apply, and if any C14 incorporation were de-
tected, the data would lack spatio-temporal precision to
determine the time of origin or specific location of cells
that synthesized DNA. In addition, as discussed above,
application of the C14 method cannot discriminate be-
tween true neuronogenesis and label incorporated during
nonproliferative DNA synthesis. A note of caution should
be added that NeuN may not be as specific for mature
neurons as recently thought. A recent report indicates
that NeuN labels human astrocytes (Darlington et al.,
2007). This could potentially complicate reports of human
neurogenesis that rely heavily on this marker.
Genetic Methods for NPC Labeling and Mutation
The methods described above only label cells synthesiz-
ing DNA and are therefore limited in their ability to deci-
pher the molecular regulation that controls the fate and
dynamics of neural precursor cells. To address these
questions, genetic approaches have been applied, includ-
ing germline transgenesis and knockout mice. Traditional
knockout mouse technology allows for both the mutation
of a gene of interest and the potential for labeling of all cells
endogenously expressing this gene with a knocked-in
marker gene. This powerful tool has led to much advance-
ment in the understanding of embryonic neurogenesis
and, in some cases, adult neurogenesis. However, creat-
ing genetically modified animals is expensive, requires
sophisticated expertise, and is time consuming. Further-
more, in many cases, global deletion of a gene disrupts
the development of the CNS, or other essential organ sys-
tems, creating a perturbed and therefore inappropriate
model for investigation of the gene’s specific role in adult
neurogenesis. Often, heterozygous knockouts are used to
overcome this drawback, but gene dosage issues still616 Cell Stem Cell 1, December 2007 ª2007 Elsevier Inc.apply and mutants can be significantly altered due to de-
velopmental abnormalities.
To avoid these limitations, new methodologies have
been developed to generate genetic modifications with
more spatio-temporal specificity. A summary of some of
these techniques and their caveats when applied to the
study of neural precursor dynamics are discussed in the
following sections (Tables 1 and 2).
Viral Vectors
A host of viral technologies is now in use to genetically la-
bel/alter cells in the study of postnatal neurogenesis (Ack-
man et al., 2006; van Praag et al., 2002), including selected
subtypes of the adeno-, lenti-, and retrovirus families
(Table 1)—each with its advantages and disadvantages
(Thomas et al., 2003). Adenovirus technology allows
transduction of a range of cell types but often requires
the use of shuttle vectors during the cloning process.
Also, the viral genome does not integrate into the host
genome and thus infection is transient. Lentivirus similarly
infects a range of cells but does not require shuttle vectors
to clone in transgenes. Lentiviruses are reverse tran-
scribed into the genome, leading to permanent insertion
into the host DNA (Thomas et al., 2003). Retroviruses spe-
cifically transduce dividing cells and, after reverse tran-
scription, are permanently incorporated in the DNA, thus
being ideal for the study of proliferating cells (Lewis and
Emerman, 1994). Cells infected by any of these virus fam-
ilies can be labeled with a reporter gene such as EGFP,
b-galactosidase, or alkaline phosphatase. Transgenes can
be overexpressed in combination with such a reporter
gene by using a second promoter or an internal ribosome
entry site (IRES), a nucleotide sequence allowing for initi-
ation of translation in the middle of an mRNA, thus allow-
ing for the expression of two distinct proteins from a single
mRNA molecule. Alternatively, a short interfering RNA
(siRNA) sequence (see below) can be transduced to cell-
autonomously knockdown a particular protein (Ge et al.,
2006).
Several characteristics of viral technologies present
both advantages and limitations to their application (Table
1). Chief among these is the minimal spread of virus in
dense tissue, necessitating stereotaxic surgery to deliver
the virus to the precise anatomical region. Once this is ac-
complished, however, viral infection can be considered
quite localized, which is experimentally advantageous. In
addition, it should be noted that the integration of lenti-
and retroviruses into random genomic locations can alter
or completely prevent the expression of the interrupted
gene. Active loci are preferentially targeted by some vi-
ruses, increasing the potential for mutation of frequently
transcribed genes (Schroder et al., 2002). Indeed, several
immune-deficient infantsdeveloped leukemiaduringapio-
neering gene therapy trial after the proviral gene transfer
vectors integrated and disrupted endogenous genes
(Hacein-Bey-Abina et al., 2003). Furthermore, as described
in detail below, a recent report (Ackman et al., 2006) calls
into question the reliability of retroviral transduction due
to the observation that postmitotic cells can be spuriously
labeled by fused infected microglia (Figure 3A).
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Method Cell Types Targeted Advantages Caveats
Knockin All Allows for observation of expression
pattern of endogenous gene
Typically disrupts gene/promoter
Specificity of phenotype determined
by endogenous gene regulation
Can cause developmental abnormalities
Knockout All Allows for observation of null or
haploinsufficient mutation
Not cell type specific
Can cause developmental abnormalities
Transgenic All Allows for gain-of function/ cell
labeling experiments in vivo
Insertion sites often random
Not cell type specific (depending on
promoter)
Can cause developmental abnormalities
Cre/loxP Typically cell type
specific
Powerful, conditional control
of gene expression
Cre toxicity
No postnatal precursor cell-specific
promoters are known, thus causing
developmental abnormalities
Temporal control based on Cre-driver
promoter
rtTa/tTa Typically cell type
specific
Allows for conditional, reversible
control of gene expression
Frequently leaky
Difficult to manipulate in the postnatal
brain
Dox-related side effects
Inducible Cre Typically cell type
specific
Powerful, inducible control
of gene expression
Cre toxicity
Tamoxifen-related side effects
Recombination ratio suffers compared
with traditional Cre driver lines
MADM Small percentage of
random clones (can be
cell type specific using
proper Cre driver line)
Elegant mosaic analysis allowing
for mutation with specific
marking of mutated clones
Cre toxicity
More faithfully models LOH Chromosomal recombination can lead
to chromosomal abnormalities
Unique method for lineage tracing Mouse engineering is cumbersome
Achieving desired recombination rate
could be challengingElectroporation
Since its introduction, in utero electroporation has revolu-
tionized the study of rodent embryonic neurogenesis (Ta-
bata and Nakajima, 2001). This technique allows relatively
easy and rapid introduction of molecular probes in peri-
ventricular neuroblasts of developing embryos (Figures
2A–2C). These probes are typically plasmids containing
a transgene or encoding an siRNA sequence designed
to achieve gain or loss of function in the electroporated
cells and typically include a reporter gene to identify the
modified cells.Gross structures such as the developing cortex, hippo-
campal primordium, or ganglionic eminences can be
selectively targeted, because the orientation of the elec-
trodes allows the DNA probe to be directed to a particular
destination. Although thismethod is ideal for studying pre-
natal development, the postnatal effects of transgenesis
can also be investigated by examining the longer-term
consequences of embryonic genetic manipulation (Rasin
et al., 2007). For example, embryos from separate
mothers were electroporated with plasmids expressing
one of the four isoforms of Numb and an enhanced greenCell Stem Cell 1, December 2007 ª2007 Elsevier Inc. 617
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revealed that radial glia were maintained in a cell-autono-
mous manner in Numb-electroporated animals when
compared with controls. Retroviral transduction would
have required four separate viral constructs, greatly
increasing the time, workload, and safety precautions
needed. Alternatively, deriving four separate transgenic
mouse lines would further increase the time and workload
needed to observe this effect. However, electroporation
studies are less feasible in older animals, due to the cur-
rent-induced damage caused to a postnatal brain. Elec-
troporation can be combined with inducible Cre technolo-
gies (discussed below) to transfer a Cre-ER-expressing
plasmid into floxed animals, or a floxed transgene into
Cre-ER animals to facilitate the study of postnatal precur-
sor cells derived from embryonic VZ precursors or other
regions (Matsuda and Cepko, 2007).
RNA Interference
RNA interference (RNAi) is a biological pathway that medi-
ates posttranscriptional gene silencing. In short, double-
stranded RNA molecules known as siRNAs mediate
sequence-specific identification and degradation of tar-
geted messenger RNA (mRNA). This allows for knock-
down of protein levels in targeted cells without the need
for complex and time-consuming genetic engineering.
siRNA technology has revolutionized biomedical research,
and the seminal researchers in the field were recently
awarded the 2006 Nobel Prize in Physiology or Medicine.
This method, in combination with viral vectors, has led to
several powerful insights into the regulation of integration
of new neurons in the dentate gyrus (Ge et al., 2006). Nev-
ertheless, off-target effects can occur. One study has
shown that a short hairpin RNA (shRNA: a hairpin-shaped
siRNA) against luciferase led to dramatic changes in the
morphology, membrane properties, and synaptic re-
sponses in neurons (Alvarez et al., 2006). As the rats
used do not express luciferase, off-target effects are the
only interpretation. So-called ‘‘scrambled’’ controls, con-
sisting of RNAs with the same composition of nucleotides
Figure 2. Emerging Methods for Neural Precursor Cell
Manipulation
(A) Electroporation: during the procedure, the embryo is exposed, a so-
lution containing the plasmid DNA is injected (B) into the lateral ventri-
cles, and a current is passed through the head, permeating the cell
membranes and moving the negatively charged DNA with it into the
ventricular wall.618 Cell Stem Cell 1, December 2007 ª2007 Elsevier Inc.as the siRNA but with a scrambled sequence, are not de-
finitive in such situations. Rescue experiments in which
complementary DNAs (cDNAs) insensitive to the RNAi se-
quence are introduced into the RNAi-expressing cells are
better alternatives. Crossvalidation using other loss-of-
function methodologies is an alternative solution (Alvarez
et al., 2006).
Recombinase-Based Systems
Recombinase systems are based on the ability of the P1
bacteriophage cyclization recombination (Cre) protein to
catalyze recombination of sequences of DNA flanked by
loxPsites (floxedsequences). TransgenicCre/loxPanimals
are usually obtained by breeding a Cre mouse containing
a Cre recombinase transgene driven by a tissue-specific
promoter to a loxP mouse containing a floxed DNA seg-
ment of interest. Under the direction of the promoter, the
recombination induced by Cre recombinase can be used
to either activate or inactivate a gene of interest.
Another recombinase system is less often used, based
on the same strategy but employing flippase recombinase
(Flp) from Saccharomyces cerevisiae and using Flp re-
combinase targets (FRT) as recognition sites. Both Cre/
loxP and Flp/FRT recombinase systems allow for condi-
tional mutagenesis, fate mapping, and transgenesis. A
nonrecombinase binary approach for transgenesis, the
Gal4/UAS system, is frequently employed in Drosophila
but has not been adopted widely for use in mice despite
the technical feasibility, demonstrated utility, and ability
to be used in a ligand-inducible manner.
To study neural precursor cells, Cre recombinase is
driven by a promoter active predominantly in this popula-
tion of cells such as nestin, or Gfap, that is also present in
mature astrocytes. Though the temporal and spatial acti-
vation of Cre is regulated by this promoter, thus avoiding
recombination prior to the onset of CNS development
and disruption of tissues outside of the nervous system,
embryonic neurogenesis is often altered, as is the case
with traditional knockout technologies. Thus, homozy-
gotes and even heterozygotes are often significantly
different than wild-type littermates at birth. Unfortunately,
to date, no promoters have been found that show activity
strictly in postnatal neural precursor cells.
Inducible Genetic Technologies
Recently, inducible Cre and Flp recombinase systems
have been developed to allow close regulation of the tim-
ing of recombination, and thus of gene expression/modi-
fication (Hunter et al., 2005; Matsuda and Cepko, 2007).
This approach circumvents the need for postnatal precur-
sor-specific promoters, as recombination can be induced
postnatally to prevent developmental abnormalities. In
these systems, ligand-dependent recombinases are em-
ployed, constructed by fusing Cre or FLP recombinases
to mutated steroid receptors (ER) that will not bind their
natural ligand but a synthetic estrogen analog, typically
4-hydroxytamoxifen (Tm) (Ganat et al., 2006; Hunter
et al., 2005; Matsuda and Cepko, 2007) (Figures 2D–
2E’). In normal conditions, Cre or Flp-estrogen receptor
(Cre-ER; Flp-ER) fusion proteins remain inactive in the
cytoplasm until Tm is bound to induce translocation to
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nase-based technologies, the Cre-ER or Flp-ER is driven
by a promoter active in the target population. As a result,
recombination is temporarily controlled by the ligand
administration and spatially restricted to the population
with the chosen promoter activity (Figure 2D), allowing
for the targeting to neural precursor cells (Ganat et al.,
2006). Cells can be inducibly mutated, a transgene can
be expressed, or a heritable reporter can be employed
to map cell fate (Breunig et al., 2007). For example,
huGFAP promoter-driven Cre-ERT2 was used to drive
Cre, heritably labeling astrocytes and the putative neural
precursor cells in the subgranular zone (Figures 2E and
2E’). Alternate nestin lines (Burns et al., 2007) have Cre ex-
pression limited to precursor cells and any cells express-
ing nestin in that immediate lineage (ependymal cells and
transient-amplifying cells). In both cases, all cells derived
from the nestin+ cells are heritably mutated or labeled with
a reporter gene after recombination (Breunig et al., 2007;
Burns et al., 2007; Ganat et al., 2006). Many mouse lines
using this type of technology already exist in the public
domain. (For an updated list see http://rakiclab.med.
yale.edu/cretmmouselines.php.)
As with other methods, there are also inherent disad-
vantages to Cre technology. First, Cre toxicity has been
demonstrated in cell lines (Silver and Livingston, 2001)
and proliferating cell populations such as neural precursor
cells. Toxicity can lead to decreased proliferation and
cell-cycle arrest (Pfeifer et al., 2001), cell death, or other
secondary effects such as hydrocephalus/ventriculome-
galy induced by chromosomal abnormalities (Forni
et al., 2006). Thus, tamoxifen-injected Cre+/WT/WT and
Cre/fl/fl or Cre/Tg controls must be employed, in addi-
tion to noninduced Cre+/fl/fl or Cre+/Tg mice (Breunig
et al., 2007). For example, it was previously mentioned
that some Nestin-Cre and Nestin-Cre-ER mouse lines
cause perinatal hydrocephalus (Forni et al., 2006). Another
group has recently used a similar Nestin-Cre-ER line to
ablate Numb in a Numblike null background (Kuo et al.,
2006), with the result being hydrocephalus/ ventriculome-
galy. This group used Cre+, tamoxifen-induced animals
to properly control for Cre toxicity as a causal factor in
hydrocephalus. However, in one case ventriculomegaly
of unknown cause was obtained after loss of function of
hedgehog signaling by ablation of floxed smoothened us-
ing a Nestin-Cre line (Balordi and Fishell, 2007). Without
the presentation of adequate controls, i.e., Cre+ nonfloxed
or heterozygote animals, it is uncertain to what degree Cre
toxicity may contribute to any resulting phenotype (Forni
et al., 2006). For example, one study has shown that
a particular Cre line used to target insulin-producing cells,
RIP-Cre, was glucose intolerant in the absence of any
floxed alleles (Lee et al., 2006). They then noted that
more than half the papers published on this RIP-Cre line
reported glucose intolerance in the absence of controls
for Cre toxicity. Similar Cre toxicity issues have been ob-
served in other fields as well (Schmidt-Supprian and
Rajewsky, 2007). Also, using current technologies, not all
reporter expression correlates with recombination at thetarget locus (Joyner and Zervas, 2006). Recombination
of paired loxP sites will be dependent on a host of factors,
including Cre levels and the loxP integration site in the
genome (Vooijs et al., 2001), resulting in varying degrees
of efficiency among different constructs and targets. In
addition, reporter genes driven by the Rosa26 promoter
(Soriano, 1999) are not always detectable in neurons de-
rived from astrocyte-like neural precursor cells in the post-
natal brain (Shimshek et al., 2002; Weber et al., 2001),
leading to inconsistent reporter or transgene expression
after tamoxifen administration. Thus, each reporter line
must be recharacterized when crossed with a new Cre
‘‘driver’’ line. Finally, to mutate and mark a desired cell
population or to create double knockouts, multiple pairs
of loxP sites are often employed. This raises the possibility
that unpaired loxP sites can recombine (even on alternate
chromosomes) and lead to chromosomal instability and
aberrant phenotypes (Van Deursen et al., 1995).
With inducible technologies, complications of strain,
age, handling, etc. grow exponentially more dramatic,
reducing the ability of groups to replicate each other’s
findings. Furthermore, sometimes there are phenotypic
discrepancies between identically handled animals with
the same genotype, differing only by litter. Also, differ-
ences in the strain and background of mice have led to
an absence of reporter or transgene expression in certain
cases (J.J.B., unpublished data). Another factor to con-
sider is leakiness of the system. Indeed, in both strains
that we have handled (GCE and Nestin-Cre-ER), we noted
leakiness in the absence of tamoxifen and spurious label-
ing by our reporter gene of fully elaborated, mature neu-
rons in nonneurogenic regions despite a survival time of
less than 1 week after tamoxifen administration (Breunig,
2007). Thus, observations of neurogenesis, especially in
previously unreported regions, must be crossvalidated.
Another problem unique to tamoxifen-inducible sys-
tems is the fact that tamoxifen is an estrogen antagonist.
Estrogen is a known modifier of cell proliferation and neu-
ral precursor cell proliferation in particular—in addition to
an expansive list of independent biological processes
that is beyond the scope of this review (Martinez-Cerdeno
et al., 2006). We did not observe any significant alteration
in the proliferation of cells in the postnatal brain in our
studies, but our delivery paradigms were designed tomin-
imize acute effects. We recommend that assays be under-
taken a minimum of 1 week after injection in order to (1)
allow clearance of tamoxifen, permitting cells to return to
normal, and (2) in the case of transgenes, allow recombi-
nation and subsequent transcription and translation, and
in the case of inducible knockouts, allow breakdown of
the endogenous protein. A recent paper describes a po-
tent effect of tamoxifen on bipolar disorders (Einat et al.,
2007). Thus, studies using inducible mice to study behav-
ioral correlates will require tamoxifen-injected Cre-nega-
tive controls and must use caution in their interpretations.
Tetracycline (Tet)-regulated genetic modification has
also been used for conditional mutagenesis in the post-
natal brain (Casper et al., 2007). In theory, this system
allows for controlled temporal and spatial regulation ofCell Stem Cell 1, December 2007 ª2007 Elsevier Inc. 619
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there is often notable leakiness and/or difficulties inducing
gene expression due to the blood-brain barrier (Casper
et al., 2007; Mansuy and Bujard, 2000).
Mosaic Analysis with Double Markers
The ability to generate genetic mosaics of homozygous
mutant and wild-type cells has been used extensively in
Drosophila to study lineage relationships and gene func-
tion (Luo, 2007). Recently, it has been elegantly adapted
for use in the mouse model system (Zong et al., 2005). It
is important to note that this systemcircumvents problems
of other Cre-based systems by simultaneously labeling
andmutating cells (Joyner and Zervas, 2006). The method
relies on several primary elements. Mice must be gener-
ated with two reciprocally chimeric marker genes—
targeted to identical chromosomal loci, containing single
loxP sites inan intron.Cre recombination causes interchro-
mosomal rearrangement, leading to functional expression
of themarker genes. Thus, a sparse smattering of clones is
labeled. Luo and colleagues were able to show a novel
relationship in the cerebellum between the stage of gener-
ation and axonal projection of granule cells, which had not
previously been appreciated with other methods, by using
this methodology (Zong et al., 2005). As in the Drosophila
mosaic analysis with a repressible cell marker (MARCM)
system, the advantage of this method is that it can be
adapted to generate easily distinguished, labeled mutant
and wild-type cells in heterozygote animals. As proof of
principle, two groups have recently modeled loss of
heterozygosity (LOH) for Trp53 (also known as P53)
(Wang et al., 2007) and Cdkn1b (also known as P27kip1)
(Muzumdar et al., 2007). Strikingly, the phenotypes were
significantly altered from thoseseen inmodelswhereevery
cell in an organism or tissue is a homozygous mutant.
Therefore, theseprinciples canbe used tomore accurately
model cancer cell biology and study lineage relationships
inmutant orwild-type neural stemcells in a rather noninva-
sive manner.
Marker genes in the mosaic analysis with double
markers (MADM) system should indicate chromosomal
stability and diminish any cell autonomous effects of aber-
rant interchromosomal recombination within the popula-
tion ofmarked cells. However, the potential for Cre toxicity
must not be ignored. It should be noted that different Cre
driver lines exhibit different rates of recombination; thus,
mouse lines must be chosen to result in sufficient clones
to be detected for quantification yet be sparse enough
to accurately examine lineage relationships (Zong et al.,
2005). The biggest hurdle in the adoption of this system
is the complex engineering of the mice. The system cur-
rently used by Luo and colleagues is limited to mutation
of genes distal to the Rosa26 locus on chromosome six.
In contrast, the group examining Trp53 could target virtu-
ally all of chromosome 11, but these mice do not carry
a marker gene. Therefore, mice will need to be generated
for use with each chromosome. If marker genes are to be
employed, identification of widely expressed promoters
such as Rosa26 will be a limiting factor on each chromo-
some. In utero electroporation could serve as a suitable620 Cell Stem Cell 1, December 2007 ª2007 Elsevier Inc.alternative to MADM in generating smaller-scale mosaics
through focal delivery of Cre/CreERT2-expressing plas-
mids into floxed mice. Of course, similar methods could
be used to deliver transgenes or RNAi molecules in control
mice.
On the Use of Endogenous Promoters
In the case of tissue-specific genetic manipulation or gene
expression profiling, endogenous promoters are often
employed to drive protein expression that mimics that of
the native gene. Unfortunately, the dynamic sequence of
differentiation can magnify differences between the ex-
pression of the endogenous protein and a transgenically
expressed protein. For example, Eomes (also known as
Tbr2) is expressed by SVZ cells that generate neurons in
the developing cortex (Englund et al., 2005) and by tran-
sit-amplifying cells in the postnatal SEZ and hippocampus
(Breunig et al., 2007). However, use of the Eomes (Tbr2)
promoter to drive GFP expression in these populations
resulted in a drastically different pattern—namely in the
embryonic cortex, GFP was expressed mostly in the
cortical plate and not the SVZ (Kwon and Hadjantonakis,
2007). Differences in protein structure and regulation
appear to be responsible; GFP protein must accumulate
to reach a threshold required for fluorescent detection.
Given that mRNA stability strongly impacts protein ex-
pression, differences between endogenous and trans-
genicmRNA regulation such as the addition of long poly(A)
tails and cis-acting elements may result in disparate
expression patterns. Indeed, reporters such as GFP and
b-galactosidase are selected specifically for their stability,
easy detectability, and ability to be amplified, often quite
distinct characteristics from the endogenous protein
driven by the same promoter. Similar discrepancies in ex-
pression are seen between endogenous protein expres-
sion and GFP in Neurog2-GFP (also known as Ngn2)
mice (Ozen et al., 2007) and nestin-GFP mice (Steiner
et al., 2006).
In addition to variations in protein characteristics, trans-
genic promoter elements often lead to markedly different
expression patterns depending on their integration site.
For example, different nestin promoter constructs can
lead to expression in the SEZ and SGZ or SEZ only. Also,
upstream and downstream promoter/enhancer elements
may not be detected or feasible for inclusion in the pro-
moter construct. Similarly, the recent development of the
GENSAT project (http://www.gensat.org) has yielded an
astounding amount of knowledge regarding the expres-
sion patterns of many genes in the rodent brain through
the use of bacterial artificial chromosome (BAC) trans-
genics. In many cases, these transgenic mice faithfully
recapitulate the endogenous pattern of gene expression
by using an EGFP reporter in expressing cells. However,
in other cases, EGFP label can vary from independent re-
ports and in situ hybridization expression patterns. This is
perhaps due to previouslymentioned issues such asEGFP
sensitivity and/or stability, but it could also be due to
important missing upstream or downstream promoter/
enhancer elements not present on the BAC constructs. It
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cies can drive different expression patterns when inserted
into transgenic mice. Gfap is noted in primate radial glia in
the developing CNS at much earlier stages than in the
rodent (Levitt et al., 1981), and this is perhaps why the hu-
man Gfap promoter allows targeting of embryonic radial
glia when inserted into the mouse genome (Ganat et al.,
2006; Zhuo et al., 2001). Strikingly, some groups have
used the Gfap promoter to specifically target postmitotic
neurons, noting a lack of Cre expression in glial cells
(Kwon et al., 2001).
Transplants for the Observation of NPC Behavior
Cell transplantationallows for theobservationof theeffects
of the host environment on neural precursor cells (Sohur
et al., 2006; Zigova and Newman, 2002). Donor cells can
be isolated from numerous sources, including the embry-
onic brain, the postnatal brain, embryonic precursor cells,
or immortalized cell lines. Prior to transplantation, cells can
be transfected or transduced to express transgenes/
reporters, or alternatively, cells can be isolated from trans-
genic ormutant animals to differentiate any intrinsic versus
extrinsic effects of genetic alterations to the host environ-
ment and/or donor cells. Nevertheless, a few technical
issues deserve highlighting. First, numerous passages in
culture or exposure to certain treatment conditions can
alter the genetic integrity of neural precursor cells, causing
cells to become tumorogenic or otherwise abnormal (Bjor-
klund et al., 2002; Roy et al., 2006). Indeed, aneuploidy has
been observed in cultures of adult neural precursor cells
(Palmer et al., 1997)—a condition that is known to confer
growth advantages to dividing cells. Another important
factor that must be considered is the possibility of fusion
of neural precursor cells, as has been reported in vitro
(Chen et al., 2006; Jessberger et al., 2007). Furthermore,
fusion of nonneuronal precursor cells with nonneuronal
(Terada et al., 2002) and neuronal (Ying et al., 2002) precur-
sor cells has been reported in vitro and in vivo (Alvarez-
Dolado et al., 2003;Weimann et al., 2003). Additionally, fu-
sion of transplanted nonneuronal precursor cells has also
been clearly demonstrated in a number of tissue organs
such as the liver (Vassilopoulos et al., 2003), intestine (Rizvi
et al., 2006), and kidney (Held et al., 2006). Therefore, pre-
vious reports of transdifferentiation of nonneural cells have
beencritically revisedand remaincontroversial,mainlydue
to these observations of fusion under similar conditions,
the dubious expression of neuronal markers, and/or spuri-
ous transfer of genetic/chemical label (Alvarez-Dolado
et al., 2003; Branda and Dymecki, 2004; Burns et al.,
2006; Choi et al., 2006; Neuhuber et al., 2004). Thus,
although fusion events are considered to be a relatively
rare phenomena in NSCs, fusion should nevertheless
warrant significant consideration in experimental design.
The use of genetic labels and/or differing host/donor labels
(i.e., transplantation of GFP-labeled donor cells into
a ubiquitously cyan fluorescent protein-expressing host)
is becoming the gold standard for validating transplanta-
tion experiments (MacLaren et al., 2006).The ‘‘Bystander’’ or ‘‘Chaperone’’ Effect of Neural
Tissue Transplant
The use of neural precursor cell transplantation for regen-
erative purposes has beenextensively examined in several
models of degenerative or acute neurological deficit. The
underlying assumption is that function can be restored if
significant amounts of neural tissue lost due to damage
or disease can be replaced. However, in some cases,
the treated animals experience a significant functional/
behavioral improvement even when the histological evi-
dence does not indicate a significant replacement of the
damaged population (Kerr et al., 2003; see Martino and
Pluchino, 2006 for review and additional references). The
cause of this apparent improvement appears to be a
‘‘bystander’’ or ‘‘chaperone’’ effect exerted by the trans-
planted neural precursors. These engrafted cells promote
tissue homeostasis, neuronal survival, and regeneration
by secretion of neurotrophic growth factors, which include
neuroprotective and immunomodulatory molecules, rather
than replace the lost or damaged population (for review
see Martino and Pluchino, 2006). For example, human
embryonic germ cells transplanted into a rat model of pa-
ralysis were able to engraft throughout the injured spinal
cord (Kerr et al., 2003). Although some transplanted cells
expressed nestin and Gfap, and only a small minority
expressed markers of neurons, the animals regained sig-
nificant functional ability, including walking, compared to
controls that had complete hindlimb paralysis. The ob-
served recovery appeared to be due to survival signals
induced by secreted factors from the transplanted embry-
onic germ-derived cells, causing recovery and reafferenta-
tion of the host’s motor neurons. Although these findings
are positive and powerful in their own right, potential for
a bystander effect should raise the burden of proof re-
quired to demonstrate that behavioral or functional recov-
ery is due to de novo neurogenesis. Also, it is uncertain
how such a prosurvival effect will transfer from animal
models to human clinical disease, where the cell loss is
more variable and time frames from injury to treatment
are usually more protracted. An initial phase 2 trial involv-
ing human stroke patients receiving an immortalized
neural cell line does not appear to show significant im-
provements, perhaps due to the lengthy delay from insult
to transplant (Kondziolka et al., 2005).
False-Positive Examples and Perspectives
A report by Loturco and colleagues serves to highlight the
appropriate steps required to avoid false-positive results
when utilizing leading edge techniques (Ackman et al.,
2006). The authors injected 134 rats with an EGFP-
expressing retrovirus in an effort to label any postnatally
generated neurons. No neurogenesis was detected, but
mature postmitotic neurons expressing EGFP were de-
tected shortly after infection, resulting from the fusion of
virus-infected proliferating microglia with existing pyrami-
dal cells (Figure 3A). Fusion with BrdU-incorporating
microglial cells was noted in vivo and in vitro. In vivo, fu-
sion of microglia was only noted in the apical dendrites.
However, in vitro, neurons with smaller, extra nucleiCell Stem Cell 1, December 2007 ª2007 Elsevier Inc. 621
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(A) Ackman et al. (2006) reported that injection of an EGFP retrovirus (RV-EGFP) activatedmicroglia, inducing proliferation (labeling with BrdU). Micro-
glial cells infected by the retrovirus particles fused to the apical dendrites of pyramidal neurons. This fusion caused EGFP labeling of the entirety of the
neuron. Somal fusion was seen in vitro, and the presence of BrdU-labeled nuclei in fused neurons in vivo could be a possibility.
(B) In another report, Burns et al. (2006) reported that thymidine analogs could be transferred from dead, prelabeled donor cells to proliferating host
cells. BrdU, bromodeoxyuridine; RV-EGFP, EGFP-expressing retrovirus; SEZ, subependymal zone; and Ep, Ependymal layer.were observed at the longest time point, raising the possi-
bility that distal dendritic fusion events can precede somal
fusion, as highlighted by Alvarez-Buylla and colleagues
(Alvarez-Dolado et al., 2003). It should also be noted that
it is possible that such a somal fusion could lead to
a BrdU+ nucleus in the cell body of a neuron, thus giving
a false positive for neurogenesis. Indeed, a recent paper
shows that fusion, at least in Purkinje cells, is a naturally
occurring process that increases with lesion and natural
aging (Magrassi et al., 2007). If the same process occurs
in other neuronal populations, it could confound any stud-
ies of de novo neurogenesis. Of course, as shown by Ack-
man et al. and as recommended above, false positives
can be avoided by combining multiple levels of analysis,
including temporal analysis of progressive differentiation
by developmental markers, and studies on the connectiv-
ity and physiological integration of labeled cells as
discussed in detail above.622 Cell Stem Cell 1, December 2007 ª2007 Elsevier Inc.Several methodological issues involving BrdU labeling
were raised in transplantation experiments by Verfaillie
and colleagues. These serve to show that (1) BrdU is not
a reliable marker for transplanted cells and (2) there is
the possibility of reutilization of S phase labels. Basically,
after transplantation of dead cells, which had been prela-
beled with BrdU in vitro when viable, the recipient tissue
exhibited numerous BrdU-labeled neurons and glia.
Exhaustive and comprehensive experiments led to the in-
terpretation that the thymidine analogs leached from dead
transplanted donor cells into proliferating host cells (Fig-
ure 3B; Burns et al., 2006). This indicates that previously
published transplant experiments that relied on BrdU
labeling should be re-examined with more current tech-
niques. Furthermore, large doses of BrdU coupled with
the high turnover rate in the neurogenic regions could
lead to a false readout of neurogenesis, as dying cells
could leach BrdU into any surrounding precursor cells
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EGFP
After hypoxia/ischemia, newborn glia in the area surrounding CA1 incorporate BrdU and express EGFP after tamoxifen induction. However, many
CA1 pyramidal cells incorporate BrdU but do not express EGFP after 6 days, indicating DNA synthesis was not due to neuronogenesis (Burns
et al., 2007). BrdU, bromodeoxyuridine; TM, tamoxifen; Pyr, stratum pyramidale; Or, stratum oriens; and pPV, posterior periventricle.(Burns et al., 2006). Thus, in a local precursor cell niche,
dividing precursor cells could theoretically be labeled
despite the fact that BrdU delivery was given in the distant
past. In fact, this label ‘‘recycling’’ phenomenon has been
observed in the developing retina (Silver, 1976).
Crossvalidation of results is paramount to definitive in-
terpretation of data. For example, we have recently shown
that inducible genetic labeling of newborn cells can be
a suitable means of crossvalidating thymidine analog
cell labeling or retroviral transduction of novel neurogenic
regions. After ischemia-hypoxia challenge to the hippo-
campus (Figure 4), many BrdU-labeled hippocampal pyra-
midal neurons could be found, but the lack of expression
of EGFP reporter in these neurons confirmed that this la-
belingwasdue to nonproliferativeDNAsynthesis (Figure 4;
Burns et al., 2007). However, neighboring, newborn glia
were readily labeled with this method, as were newborn
SEZ cells. The nonproliferative origin of BrdU incorpora-
tion in CA1 cells was further confirmed by the absence
of migrating cells and the fact that the neurons were
labeled with BrdU within 6 days of the insult—a period
of time that is likely too short to allow for migration and
integration of newborn pyramidal cells.
Conclusion
The exponential increase in research on neural precursor
cells in the last decade has provided an enormous body
of data, providing a foundation for the design of treat-
ments for select neurological and psychiatric disorders.
However, this field has generated an unfortunately large
number of unconfirmed or disputed findings due to what
seem to be primarily methodological problems. In this
review, we have highlighted advantages and caveats of
a wide variety of techniques used to study postnatal neu-
ral precursor cells, in hopes that more rigorous criteria are
adopted in the interpretation, validation, and peer review
of findings in this field. Dramatic findings require well-sup-
ported and crossvalidated supporting evidence. There-
fore, the rigorous use and combination of techniques arecrucial for obtaining reliable data. Without the ability to
replicate data between laboratories, progress could easily
slow and become less sound as groups unknowingly build
upon shaky scientific foundations, while others take on the
challenge of publishing negative findings to increase the
overall rigor of the field. Given the advances in the molec-
ular and genetic approaches available, what we put
forward seems cautious and reasonable.
Due to limited space, some important techniques and
approaches have been omitted or covered incompletely.
Certainly, many additional combinations of the techniques
we discuss are possible. Our hope is that this review will
encourage authors and reviewers to meet the highest sci-
entific criteria for the advancement of this fast-evolving
field, by the adoption of new techniques and by crossva-
lidation of results in a rigorous and definitive manner.
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